Mycronic revenue and financials

MYCR · Nasdaq Stockholm · SEK

kr 346.40Change from previous close: −3.51%Absolute change: −kr 12.60

Close · October 7, 2026

In the fiscal year ended December 2025, Mycronic reported revenue of kr 7.94B (+12.48% year over year). Net income was kr 1.56B, a net margin of 19.7%.

Annual revenue · 2025: kr 7.94B
  1. kr 5.12B2022
  2. kr 5.71B2023
  3. kr 7.06B2024
  4. kr 7.94B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+12.48%
2025 vs 2024
Net income growth
−7.31%
2025 vs 2024
Net margin
19.7%
2024: 23.8%

Financial data

Amounts in millions of SEK; per-share values in SEK; shares in millions.

Balance sheet · Annual
Item20252024202320222021
Total assets10,92210,4128,3407,340—
Current assets6,4496,8795,3194,195—
Cash and equivalents2,3233,0142,1401,274—
Inventory2,1502,0561,6021,433—
Net property, plant and equipment697574495513—
Goodwill2,6462,1051,8031,866—
Other intangible assets878581489508—
Current liabilities2,7983,2052,5072,062—
Accounts payable465557388310—
Long-term debt12.0—0.07.00.0
Total debt348219228270—
Total liabilities3,8133,8373,0572,637—
Total equity (incl. minority)7,1096,5755,2834,703—
Retained earnings5,5734,7093,4872,853—
Minority interest0.043.036.040.0—